Br J Pharmacol 179:625641 Koob GF, Volkow ND (2010) Neurocircuitry of addiction
Other studies have put that range between 15 and 40 percent, depending on the protocol
The PA criteria require BMI 30 or higher (or 27 with a comorbidity such as type 2 diabetes, hypertension, dyslipidemia, OSA, or CVD), documentation of a 6-month structured weight management program, prescriber attestation that lifestyle change alone has failed, and age 18 or older
That said, people with a significant amount of weight to lose, like those with a BMI over 40 or more than 100 lbs to shed, are generally more likely to experience loose skin when reaching a healthier weight
Some of the most significant keypoints about tirzepatide include: FDA Approval: Tirzepatide is FDA-approved for chronic weight management under the brand name Zepbound for adults with obesity or those who are overweight with weight-related medical problems